In recent years, TAZ has been observed to be overexpressed in several tumors, including thyroid carcinoma[18], rectal cancer[17], and colon cancer[16], suggesting it may function as a promoter in tumorigenesis. Here, TAFAZZIN is linked to thyroid gland carcinoma.